论文部分内容阅读
随机选择未能有效控制血糖的120例GDM患者作为实验对象,并随机均分为对照组和观察组,观察组患者进行门冬胰岛素治疗,对照组患者采用生物合成人胰岛素治疗。结果与对照组相比,观察组在妊娠期出现并发症的患者数目明显减少,差异显著,具有统计学意义(P<0.05);观察组患者的血糖在餐前、餐后2 h、空腹及夜间四种情况下达标的平均天数与对照组相比明显减少,差异显著,具有统计学意义(P<0.05)。结论门冬胰岛素治疗GDM相比于生物合成人胰岛素具有更优的临床疗效。
120 cases of GDM patients who failed to effectively control blood glucose were randomly selected as experimental subjects and randomly divided into control group and observation group. Patients in observation group were treated with insulin aspart as the control group, and patients in control group were treated with biosynthesis of human insulin. Results Compared with the control group, the number of patients in the observation group during pregnancy significantly decreased, the difference was significant (P <0.05); the observation group patients with blood glucose in the pre-meal, postprandial 2 h, fasting and The average number of days reached the standard in four cases at night was significantly reduced compared with the control group, the difference was significant, with statistical significance (P <0.05). Conclusion Aspart insulin treatment of GDM compared with biosynthesis of human insulin has better clinical efficacy.